Brigham and Women’s Hospital is a world leader in clinical research, a critical aspect of improving heart and vascular care.
A clinical trial is a carefully controlled study of the safety and effectiveness of a medical treatment, strategy, device, or other intervention for humans. By participating in a clinical trial, which is strictly voluntary, a patient may help researchers discover a new life-saving medication or surgical procedure.
Recent clinical trials at Brigham and Women's Hospital have demonstrated that: thrombolytic therapy (clot-busting drugs) could significantly improve a patient's chance of survival following a heart attack; aspirin could prevent a first heart attack; ACE inhibitors could save lives and protect against left ventricular enlargement following a heart attack, and cholesterol-lowering medication could save lives in patients following a first heart attack. Building upon these medical breakthroughs, we continue to search for the next medical advance that will help our patients and patients throughout the world.
Access information on Blood, Heart and Circulation Clinical Trials at Brigham and Women’s Hospital.
Access information on Mass General Brigham Blood, Heart and Circulation Clinical Trials.
